Beta-Blockers in Cirrhosis Patients With Refractory Ascites

被引：32
|
作者：
Robins, Anne [1 ]
Bowden, Anne [1 ]
Watson, William [1 ]
Smith, Fiona [1 ]
Gelson, William [1 ]
Griffiths, William [1 ]
机构：
[1] Addenbrookes Hosp, Cambridge, England
来源：
HEPATOLOGY | 2014年 / 59卷 / 05期
关键词：
DYSFUNCTION;
D O I：
10.1002/hep.26676
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2054 / 2055
页数：2
相关论文
共 50 条
  • [21] Beta-blockers in the era of precision medicine in patients with cirrhosis
    Albillos, Agustin
    Krag, Aleksander
    JOURNAL OF HEPATOLOGY, 2023, 78 (04) : 866 - 872
  • [22] Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis
    Groszmann, RJ
    Garcia-Tsao, G
    Bosch, J
    Grace, ND
    Burroughs, AK
    Planas, R
    Escorsell, A
    Garcia-Pagan, JC
    Patch, D
    Matloff, DS
    Gao, H
    Makuch, R
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21): : 2254 - 2261
  • [23] Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
    Sauerbruch, Tilman
    Hennenberg, Martin
    Trebicka, Jonel
    Schierwagen, Robert
    FRONTIERS IN MEDICINE, 2023, 9
  • [24] NONSELECTIVE BETA-BLOCKERS IN PATIENTS WITH CIRRHOSIS: "THE THERAPEUTIC WINDOW"
    Dimache, Mihaela
    Girleanu, Irina
    Carpov, Eleonora
    Trifan, Anca
    Stanciu, C.
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2016, 120 (01): : 23 - 28
  • [25] THE PRESENCE OF ESOPHAGEAL VARICES (EV), BUT NOT TREATMENT WITH BETA-BLOCKERS, IS ASSOCIATED WITH A POORER SURVIVAL IN PATIENTS WITH CIRRHOSIS AND ASCITES
    Zipprich, Alexander
    Garcia-Tsao, Guadalupe
    Seufferlein, Thomas
    Dollinger, Matthias M.
    HEPATOLOGY, 2011, 54 : 460A - 461A
  • [26] Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites
    Ferrarese, Alberto
    Tikhonoff, Valerie
    Casiglia, Edoardo
    Angeli, Paolo
    Fasolato, Silvano
    Faggian, Diego
    Zanetto, Alberto
    Germani, Giacomo
    Russo, Francesco Paolo
    Burra, Patrizia
    Senzolo, Marco
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [27] DOES THE USE OF NON-SELECTIVE BETA-BLOCKERS IN CIRRHOSIS PATIENTS WITH ASCITES RESULT IN INCREASED MORTALITY?
    Mallawaarachchi, N.
    Sinha, R.
    Hayes, P.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S278 - S279
  • [28] Optimal resting heart rate and ascites-related death in patients with cirrhosis and ascites using nonselective beta-blockers (ORCA)
    Mingpun, Warunee
    Sobhonslidsuk, Abhasnee
    Chumnumwat, Supatat
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):
  • [29] ACTION OF BETA-BLOCKERS IN DECOMPENSATED CIRRHOSIS
    DUPUIS, O
    MARTIN, H
    GAUTHIER, A
    PAULIN, R
    NOUVELLE PRESSE MEDICALE, 1976, 5 (02): : 91 - 91
  • [30] Beta-Blockers in Cirrhosis: Friend and Foe?
    Wong, Florence
    Salerno, Francesco
    HEPATOLOGY, 2010, 52 (03) : 811 - 813
12345